Our finding revealed that FTY720 administration in obese mice could protect against obesity and insulin resistance via changes in adipose tissue inflammation, suggesting that pharmacological inhibition of TRPM7 using FTY720 may also benefit patients with obesity and others with insulin resistance. This evidence concerns the gene TRPM7 and obesity due to melanocortin 4 receptor deficiency.